Skip to main content

OpGen signs deal with New York health department to research superbugs

The Maryland biotech hopes its new superbug contract with Merck and the state of New York puts it on the national map for drug-resistant disease research.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.